查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1701872

循環腫瘤細胞市場報告（按技術、應用、產品、樣本、最終用戶和地區）2025-2033

Circulating Tumor Cells Market Report by Technology, Application, Product, Specimen, End User, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 137 Pages | 商品交期: 2-3個工作天內

價格

2024 年全球循環腫瘤細胞 (CTC) 市場規模達 129 億美元。展望未來， IMARC Group預計到 2033 年市場規模將達到 278 億美元，2025-2033 年期間的成長率 (CAGR) 為 8.46%。由於生活方式的改變，遺傳性疾病的盛行率不斷上升，推動了市場的發展。

循環腫瘤細胞 (CTC) 是從原發性腫瘤中分離出來的癌細胞，以單一單位或簇的形式出現在循環系統中。它們具有不同的生物學表現型，例如上皮、間質和混合上皮-間質。患者血液中的 CTC 水平可以早期發現癌症並作為預後指標。由於數量極少，因此使用多種技術來分離、富集和檢測 CTC，例如免疫捕獲、基於尺寸的分離、基於密度的分離和顯微鏡檢查。它在液體活體組織切片、癌症研究、藥物開發和臨床生物標記方面也有廣泛的應用。

循環腫瘤細胞（CTC）市場趨勢：

由於遺傳疾病導致的癌症盛行率不斷上升、酒精消費量不斷增加以及生活方式的快速變化是推動市場成長的關鍵因素。 CTC有助於肺癌、乳腺癌、消化道癌和前列腺癌的早期識別和即時監測。與此一致，CTC 在患者轉移篩檢和新型抗癌藥物臨床前研究的應用日益增多，有利於市場成長。此外，對微創（MI）診斷程序的需求不斷成長，以及基於 CTC 的液體活體組織切片的廣泛採用以實現快速恢復和限制創傷，為市場成長提供了相當大的推動力。除此之外，引入奈米技術來提高 CTC 分離和檢測的靈敏度和效率，為市場成長提供了動力。此外，在醫學研究中擴大利用細胞培養模型來開發藥物篩選、疾病建模、基因組編輯和腫瘤免疫，為市場創造了積極的前景。此外，醫療保健專業人員和患者對早期癌症診斷重要性的認知不斷提高，這對市場成長產生了積極影響。其他因素，包括生物醫學影像和生物工程技術的快速進步、廣泛的研究和開發 (R&D) 活動以及對預防醫學和伴隨診斷的不斷成長的需求，預計將推動市場成長。

本報告回答的關鍵問題

  • 2024 年全球循環腫瘤細胞 (CTC) 市場規模？ 2025 年至 2033 年期間全球循環腫瘤細胞 (CTC) 市場的預期成長率為何？
  • 推動全球循環腫瘤細胞 (CTC) 市場發展的關鍵因素有哪些？
  • COVID-19 對全球循環腫瘤細胞 (CTC) 市場有何影響？
  • 基於技術，全球循環腫瘤細胞（CTC）市場如何分佈？
  • 根據應用，全球循環腫瘤細胞 (CTC) 市場如何分佈？
  • 根據產品，全球循環腫瘤細胞 (CTC) 市場如何分佈？
  • 根據樣本，全球循環腫瘤細胞 (CTC) 市場如何分佈？
  • 全球循環腫瘤細胞（CTC）市場的主要區域有哪些？
  • 全球循環腫瘤細胞 (CTC) 市場的主要參與者/公司有哪些？

目錄

第1章：前言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 次要來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章：執行摘要

第4章：簡介

  • 概述
  • 主要行業趨勢

第5章：全球循環腫瘤細胞（CTC）市場

  • 市場概覽
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章：市場區隔：依技術

  • CTC檢測和富集方法
  • CTC直接檢測方法
  • CTC分析

第7章：市場區隔：依應用

  • 臨床/液體活體組織切片
    • 關鍵部分
      • 風險評估
      • 篩檢和監測
  • 研究
    • 關鍵部分
      • 癌症幹細胞與腫瘤發生研究
      • 藥物/療法開發

第8章：市場區隔：依產品

  • 試劑盒和試劑
  • 採血管
  • 設備或系統

第9章：市場區隔：依樣本

  • 血
  • 骨髓
  • 其他體液

第10章：市場區隔：依最終用戶

  • 醫院和診所
  • 研究與學術機構
  • 診斷中心

第 11 章：市場區隔：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場區隔：依國家

第 12 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 13 章：價值鏈分析

第 14 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 15 章：價格分析

第 16 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • BioFluidica Inc
    • Creatv MicroTech Inc.
    • CytoLumina Technologies Corp.
    • Fluxion Biosciences Inc.
    • Greiner Bio-One International GmbH
    • Ikonisys Inc
    • Menarini Silicon Biosystems
    • Miltenyi Biotec
    • Qiagen NV
    • Rarecells Diagnostics
    • Stemcell Technologies
Product Code: SR112025A6316

The global circulating tumor cells (CTC) market size reached USD 12.9 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 27.8 Billion by 2033, exhibiting a growth rate (CAGR) of 8.46% during 2025-2033. The rising prevalence of genetic disorders, owing to lifestyle changes, is propelling the market.

Circulating tumor cells (CTC) are cancer cells that split away from the primary tumor and appear in the circulatory system as singular units or clusters. They have different biological phenotypes, such as epithelial, mesenchymal, and mixed epithelial-mesenchymal. CTC levels in a patient's blood can allow early detection of cancer and act as a prognostic indicator. As they are in minimal quantity, several technologies are used for the isolation, enrichment, and detection of CTC, such as immunocapture, size-based separation, density-based separation, and microscopy. It also has wide-ranging applications in liquid biopsy, cancer research, drug development, and clinical biomarkers.

Circulating Tumor Cells (CTC) Market Trends:

The increasing prevalence of cancer due to genetic disorders, rising alcohol consumption, and rapid lifestyle changes are key factors driving the market growth. CTC assists in the early identification and real-time monitoring of lung, breast, digestive tract, and prostate cancer. In line with this, the increasing utilization of CTC in patient screening for metastasis and preclinical studies of new cancer drugs is favoring the market growth. Furthermore, the growing demand for minimally invasive (MI) diagnostic procedures and widespread adoption of CTC-based liquid biopsy to enable rapid recovery and limit trauma are providing a considerable boost to the market growth. Apart from this, the introduction of nanotechnology to improve the sensitivity and efficiency of CTC isolation and detection is providing an impetus to market growth. Moreover, increasing utilization in medical research to develop cell culture models for drug screening, disease modeling, genome editing, and tumor immunity is creating a positive outlook for the market. Additionally, the increasing awareness amongst healthcare professionals and patients about the importance of early cancer diagnosis is positively influencing the market growth. Other factors, including rapid advancements in biomedical imaging and bioengineering technology, extensive research and development (R&D) activities, and the rising demand for preventive medicine and companion diagnostics, are anticipated to drive the market growth.

Key Market Segmentation:

Breakup by Technology:

  • CTC Detection and Enrichment Method
  • CTC Direct Detection Methods
  • CTC Analysis

Breakup by Application:

  • Clinical/Liquid Biopsy
  • Risk Assessment
  • Screening and Monitoring
  • Research
  • Cancer Stem Cell and Tumorigenesis Research
  • Drug/Therapy Development

Breakup by Product:

  • Kits and Reagents
  • Blood Collection Tubes
  • Devices and Systems

Breakup by Specimen:

  • Blood
  • Bone Marrow
  • Other Body Fluids

Breakup by End User:

  • Hospital and Clinics
  • Research and Academic Institutes
  • Diagnostic Centres

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being BioFluidica Inc, Creatv MicroTech Inc., CytoLumina Technologies Corp., Fluxion Biosciences Inc., Greiner Bio-One International GmbH, Ikonisys Inc, Menarini Silicon Biosystems, Miltenyi Biotec, Qiagen N.V, Rarecells Diagnostics and Stemcell Technologies.

Key Questions Answered in This Report

  • 1.What was the size of the global Circulating Tumor Cells (CTC) market in 2024?
  • 2.What is the expected growth rate of the global Circulating Tumor Cells (CTC) market during 2025-2033?
  • 3.What are the key factors driving the global Circulating Tumor Cells (CTC) market?
  • 4.What has been the impact of COVID-19 on the global Circulating Tumor Cells (CTC) market?
  • 5.What is the breakup of the global circulating tumor cells (CTC) market based on technology?
  • 6.What is the breakup of the global Circulating Tumor Cells (CTC) market based on the application?
  • 7.What is the breakup of the global Circulating Tumor Cells (CTC) market based on the product?
  • 8. What is the breakup of the global Circulating Tumor Cells (CTC) market based on the specimen?
  • 9.What are the key regions in the global Circulating Tumor Cells (CTC) market?
  • 10.Who are the key players/companies in the global Circulating Tumor Cells (CTC) market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Circulating Tumor Cells (CTC) Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Technology

  • 6.1 CTC Detection and Enrichment Method
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 CTC Direct Detection Methods
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 CTC Analysis
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Clinical/Liquid Biopsy
    • 7.1.1 Market Trends
    • 7.1.2 Key Segments
      • 7.1.2.1 Risk Assessment
      • 7.1.2.2 Screening and Monitoring
    • 7.1.3 Market Forecast
  • 7.2 Research
    • 7.2.1 Market Trends
    • 7.2.2 Key Segments
      • 7.2.2.1 Cancer Stem Cell and Tumorigenesis Research
      • 7.2.2.2 Drug/Therapy Development
    • 7.2.3 Market Forecast

8 Market Breakup by Product

  • 8.1 Kits and Reagents
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Blood Collection Tubes
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Devices or Systems
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Specimen

  • 9.1 Blood
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Bone Marrow
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Other Body Fluids
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by End User

  • 10.1 Hospital and Clinics
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Research and Academic Institutes
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Diagnostic Centres
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia-Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 BioFluidica Inc
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
    • 16.3.2 Creatv MicroTech Inc.
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
    • 16.3.3 CytoLumina Technologies Corp.
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
    • 16.3.4 Fluxion Biosciences Inc.
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
    • 16.3.5 Greiner Bio-One International GmbH
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
    • 16.3.6 Ikonisys Inc
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
    • 16.3.7 Menarini Silicon Biosystems
      • 16.3.7.1 Company Overview
      • 16.3.7.2 Product Portfolio
    • 16.3.8 Miltenyi Biotec
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
    • 16.3.9 Qiagen N.V
      • 16.3.9.1 Company Overview
      • 16.3.9.2 Product Portfolio
    • 16.3.10 Rarecells Diagnostics
      • 16.3.10.1 Company Overview
      • 16.3.10.2 Product Portfolio
    • 16.3.11 Stemcell Technologies
      • 16.3.11.1 Company Overview
      • 16.3.11.2 Product Portfolio

List of Figures

  • Figure 1: Global: Circulating Tumor Cells Market: Major Drivers and Challenges
  • Figure 2: Global: Circulating Tumor Cells Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Circulating Tumor Cells Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Circulating Tumor Cells Market: Breakup by Technology (in %), 2024
  • Figure 5: Global: Circulating Tumor Cells Market: Breakup by Application (in %), 2024
  • Figure 6: Global: Circulating Tumor Cells Market: Breakup by Product (in %), 2024
  • Figure 7: Global: Circulating Tumor Cells Market: Breakup by Specimen (in %), 2024
  • Figure 8: Global: Circulating Tumor Cells Market: Breakup by End User (in %), 2024
  • Figure 9: Global: Circulating Tumor Cells Market: Breakup by Region (in %), 2024
  • Figure 10: Global: Circulating Tumor Cells (CTC Detection and Enrichment Method) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Circulating Tumor Cells (CTC Detection and Enrichment Method) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Circulating Tumor Cells (CTC Direct Detection Methods) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Circulating Tumor Cells (CTC Direct Detection Methods) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Circulating Tumor Cells (CTC Analysis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Circulating Tumor Cells (CTC Analysis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Circulating Tumor Cells (Clinical/Liquid Biopsy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Circulating Tumor Cells (Clinical/Liquid Biopsy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Circulating Tumor Cells (Research) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Circulating Tumor Cells (Research) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Circulating Tumor Cells (Kits and Reagents) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Circulating Tumor Cells (Kits and Reagents) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Circulating Tumor Cells (Blood Collection Tubes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Circulating Tumor Cells (Blood Collection Tubes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Circulating Tumor Cells (Devices or Systems) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Circulating Tumor Cells (Devices or Systems) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Circulating Tumor Cells (Blood) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Circulating Tumor Cells (Blood) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Circulating Tumor Cells (Bone Marrow) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Circulating Tumor Cells (Bone Marrow) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Global: Circulating Tumor Cells (Other Body Fluids) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Global: Circulating Tumor Cells (Other Body Fluids) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Global: Circulating Tumor Cells (Hospital and Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Global: Circulating Tumor Cells (Hospital and Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Global: Circulating Tumor Cells (Research and Academic Institutes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Global: Circulating Tumor Cells (Research and Academic Institutes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Global: Circulating Tumor Cells (Diagnostic Centres) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Global: Circulating Tumor Cells (Diagnostic Centres) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: North America: Circulating Tumor Cells Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: North America: Circulating Tumor Cells Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: United States: Circulating Tumor Cells Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: United States: Circulating Tumor Cells Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Canada: Circulating Tumor Cells Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Canada: Circulating Tumor Cells Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Asia-Pacific: Circulating Tumor Cells Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Asia-Pacific: Circulating Tumor Cells Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: China: Circulating Tumor Cells Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: China: Circulating Tumor Cells Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Japan: Circulating Tumor Cells Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Japan: Circulating Tumor Cells Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: India: Circulating Tumor Cells Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: India: Circulating Tumor Cells Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: South Korea: Circulating Tumor Cells Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: South Korea: Circulating Tumor Cells Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Australia: Circulating Tumor Cells Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Australia: Circulating Tumor Cells Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Indonesia: Circulating Tumor Cells Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Indonesia: Circulating Tumor Cells Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Others: Circulating Tumor Cells Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Others: Circulating Tumor Cells Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Europe: Circulating Tumor Cells Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Europe: Circulating Tumor Cells Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Germany: Circulating Tumor Cells Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Germany: Circulating Tumor Cells Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: France: Circulating Tumor Cells Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: France: Circulating Tumor Cells Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: United Kingdom: Circulating Tumor Cells Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: United Kingdom: Circulating Tumor Cells Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Italy: Circulating Tumor Cells Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Italy: Circulating Tumor Cells Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Spain: Circulating Tumor Cells Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Spain: Circulating Tumor Cells Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Russia: Circulating Tumor Cells Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Russia: Circulating Tumor Cells Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Others: Circulating Tumor Cells Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Others: Circulating Tumor Cells Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Latin America: Circulating Tumor Cells Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Latin America: Circulating Tumor Cells Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 78: Brazil: Circulating Tumor Cells Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 79: Brazil: Circulating Tumor Cells Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 80: Mexico: Circulating Tumor Cells Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 81: Mexico: Circulating Tumor Cells Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 82: Others: Circulating Tumor Cells Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 83: Others: Circulating Tumor Cells Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 84: Middle East and Africa: Circulating Tumor Cells Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 85: Middle East and Africa: Circulating Tumor Cells Market: Breakup by Country (in %), 2024
  • Figure 86: Middle East and Africa: Circulating Tumor Cells Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 87: Global: Circulating Tumor Cells Industry: SWOT Analysis
  • Figure 88: Global: Circulating Tumor Cells Industry: Value Chain Analysis
  • Figure 89: Global: Circulating Tumor Cells Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Circulating Tumor Cells Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Circulating Tumor Cells Market Forecast: Breakup by Technology (in Million USD), 2025-2033
  • Table 3: Global: Circulating Tumor Cells Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 4: Global: Circulating Tumor Cells Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 5: Global: Circulating Tumor Cells Market Forecast: Breakup by Specimen (in Million USD), 2025-2033
  • Table 6: Global: Circulating Tumor Cells Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 7: Global: Circulating Tumor Cells Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 8: Global: Circulating Tumor Cells Market: Competitive Structure
  • Table 9: Global: Circulating Tumor Cells Market: Key Players